Recommendations for the implementation of WHO Framework Convention on Tobacco Control Article 14 on tobacco cessation support by Raw, Martin et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1111/add.13893
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Raw, M., Ayo-Yusuf, O., Chaloupka, F., Fiore, M., Glynn, T., Hawari, F., ... Reddy, S. (2017). Recommendations
for the implementation of WHO Framework Convention on Tobacco Control Article 14 on tobacco cessation
support. Addiction. https://doi.org/10.1111/add.13893
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
Improving implementation of FCTC Article 14 
 
1 
 
Recommendations for the implementation of WHO Framework Convention on 
Tobacco Control Article 14 on tobacco cessation support 
 
Martin Raw, Visiting Professor, Department of Population Health, New York University School 
of Medicine, New York, USA and UK Centre for Tobacco and Alcohol Studies, Division of 
Epidemiology and Public Health, University of Nottingham, Nottingham, UK 
 
Olalekan Ayo-Yusuf, Professor and Dean, Faculty of Health Sciences, Sefako Makgatho Health 
Sciences University, Pretoria, South Africa  
lekan.ayo-yusuf@smu.ac.za 
 
Frank Chaloupka, Director, Health Policy Center, Institute for Health Research and Policy, 
University of Illinois at Chicago, Chicago, USA 
fjc@uic.edu 
 
Michael Fiore, Director, Center for Tobacco Research and Intervention and Professor of Medicine, 
University of Wisconsin School of Medical and Public Health, Madison, USA 
mcf@ctri.medicine.wisc.edu 
 
Thomas Glynn, Consulting Professor, Stanford Prevention Research Center, School of Medicine, 
Stanford University, Palo Alto, USA 
tomglynn7@gmail.com 
 
Feras Hawari, Director, Cancer Control Office and Chief, Section of Pulmonary and Critical Care, 
King Hussein Cancer Center, Amman, Jordan 
fhawari@khcc.jo 
 
Judith Mackay, Senior Advisor, Vital Strategies, and Director, Asian Consultancy on Tobacco 
Control, Hong Kong 
jmackay1@netvigator.com 
 
Ann McNeill, Professor of Tobacco Addiction, UK Centre for Tobacco & Alcohol Studies, 
National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College 
London, London, UK 
ann.mcneill@kcl.ac.uk 
 
Srinath Reddy, President, Public Health Foundation of India, Delhi NCR, Gurgaon, Haryana, India 
ksrinath.reddy@phfi.org 
 
Corresponding author: Martin Raw martin@martinraw.com 
 
Word count: 2620 
 
Key words: tobacco cessation, tobacco dependence treatment, FCTC Article 14 
 
 
 
 
 
 
 
Improving implementation of FCTC Article 14 
 
2 
 
Article 14 of the Framework Convention for Tobacco Control recommends provision of evidence-
based support for tobacco cessation. However, it is being implemented very slowly in most 
countries, so that by 2014 only a small minority of the world's tobacco users have access to 
appropriate cessation support, according to WHO. This editorial, endorsed by more than 60 global 
leaders in tobacco cessation (see online version), sets out actions that countries can take to remedy 
the situation, focusing on low cost, broad reach interventions. 
 
Introduction 
 
Stopping tobacco use is a vital element in any comprehensive approach to tobacco control. It saves 
lives, prevents debilitating illnesses and is beneficial economically (3), not least by reducing 
healthcare costs (4). Recognizing this, the World Health Organization oversaw the development of 
the world’s first global health treaty, the Framework Convention on Tobacco Control (WHO 
FCTC), which entered into force in 2005, and includes an Article on tobacco cessation (Article 14). 
The FCTC is one of the most widely supported of all United Nations (UN) treaties. At the time of 
writing 179 countries (180 Parties), representing 90% of the world’s population, have ratified the 
Treaty (1). In 2010 the fourth Conference of the Parties to the Treaty adopted guidelines to assist 
Parties in implementing Article 14 of the Treaty, on tobacco dependence and cessation (2). 
 
Since 2010, several important international initiatives have provided further impetus for the 
implementation of the FCTC and Article 14 of the Treaty: 
 
 In 2011 the United Nations General Assembly held a special session at which it adopted a 
political declaration on non-communicable diseases (NCDs), which recognized tobacco as 
one of the four main NCD risk factors and committed governments to accelerated 
implementation of the FCTC (5). 
 In 2013 the World Health Assembly adopted voluntary global targets on NCDs, including a 
25% decrease in premature mortality from NCDs by 2025 and a 30% relative reduction in 
tobacco use by the same year (6) compared with a 2010 baseline.  
 In 2015 world leaders agreed to an ambitious set of Sustainable Development Goals (SDGs). 
Goal 3 (“Ensure healthy lives and promote well-being for all at all ages”) includes a target 
of reducing premature mortality from NCDs by 33% by 2030, and goal 3a is to strengthen 
implementation of the FCTC in all countries (7). 
 
Thus there is strong international support to strengthen and accelerate full implementation of the 
WHO FCTC. While preventing people from starting smoking and using other forms of tobacco will 
save lives twenty years and more from now, only effective tobacco cessation will have a sufficient 
effect on mortality in the few years left to reach the UN/WHO goal of a 25% reduction in premature 
mortality from NCDs by 2025. Failure on that front will surely thwart the global aspiration for success 
in NCD control and fail to save millions of current smokers’ lives (8). 
 
A neglected Article 
 
The 2014 WHO Global Progress Report notes that in general good progress is being made in FCTC 
implementation (although it notes that only 19% of Parties have implemented it to the “highest level”) 
but that some Treaty articles are being implemented more quickly than others (9). The report shows 
that by 2014 the strongest focus was on Articles 8 (restrictions on smoking in public places), 16 
(restrictions on sales to minors), 11 (large health warnings) and 12 (educational programmes), which 
motivate tobacco users to seek treatment for tobacco dependence. Only half of Parties reported that 
they were implementing Article 14, on tobacco dependence and cessation, a finding consistent with 
that of another survey suggesting slow implementation of Article 14 (10). Evidence from the survey  
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suggests that perceived cost may be one reason for hesitation in addressing tobacco treatment 
support. Another reason may be lack of clarity about the effectiveness and cost effectiveness of 
tobacco dependence treatment. 
 
There is little doubt that implementation of FCTC Article 14 and its guidelines will bring health and 
economic benefits to countries (3). Helping smokers to stop is a highly cost effective healthcare 
intervention which saves lives (11, 12, 13, 14, 15), improves population health by reducing both 
morbidity and mortality (16, 17, 18) and can reduce health-care costs (4). Every day that smokers 
over 35 years old continue to smoke they lose about 3–6 hours of life (19). So for the world’s 
estimated 1 billion current smokers (3), about half of them over 35 (20), 62 million days of life are 
lost every day. Some of these will stop unaided. Many others will stop only after repeated attempts 
over time. Many more smokers will never stop and will die before they can stop (21), mainly because 
tobacco use is so addictive (2, 22, 23, 24). Arguably treatment support should be provided along with 
measures like restrictions on smoking in public places and other measures mentioned in the FCTC 
(25). While other tobacco control policies, such as tax increases and smokefree air laws, primarily 
increase quit attempts, evidence shows that comprehensive cessation treatment policies primarily 
affect quit success (12). Combining cessation treatment with other policies creates a synergistic 
impact that improves the effect of other policies. The unaided tobacco cessation rate at six to twelve 
months is low, only about 3–5% (26). Adding comprehensive cessation support can increase this 
considerably, at least doubling it (12, 18, 27, 28), but even brief advice improves cessation rates 
significantly. Its long term rate is much lower, but applied at population level it would still result in 
significant population health gain (27). One reason why so many people who eventually end up as ex-
smokers have stopped without help is not because attempting to quit without help is the most effective 
method, but simply because many of them had no access to help. If they had had access to support, 
they may have stopped sooner, and many life years could have been saved. Additionally, many 
smokers who never stopped might have managed to do so if support had been available and 
accessible. According to WHO just 15% of the world’s population have access to appropriate 
cessation support (29), and even among this 15% many do not use the support that is available (30). 
And although less is known about smokeless tobacco use clearly a comprehensive approach is 
required for cessation (31, 32). 
 
There is thus a significant unmet need for tobacco cessation support. Although some tobacco users do 
stop unaided, many more would stop if they had access to effective support. The FCTC Article 14 
Guidelines recommend how to address this need in a way that is appropriate to the situation of the 
country, and which makes best use of existing resources. Improving cessation support need not be 
expensive, and helping smokers stop sooner rather than later will not only save many lives but 
improve the quality of life of those who do stop. 
 
Because of these considerations, and because the FCTC Article 14 Guidelines contain clear and 
feasible recommendations, we believe the time has come to re-evaluate the role of cessation 
support, especially because effective, low-cost, broad-reach approaches exist that can be 
implemented quickly (27). Revenue could be raised for tobacco control and cessation from tobacco 
tax increases (3, 33, 34) and evidence from some countries suggests that public support for such tax 
increases is stronger if some of the money is spent offering support to tobacco users who need it, 
many of whom are poor and for whom tobacco use is a financial strain (35). 
 
Some underlying principles 
 
The FCTC Article 14 Guidelines include the following key underlying principles: 
 
 Implementing cessation support measures in conjunction with population level interventions 
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covered by other FCTC articles will have a synergistic effect and maximize their impact. 
 Some Parties will want or need to follow a stepwise approach in developing tobacco 
cessation support that focuses first on what is feasible and affordable, and then on what can 
be added when more resources are available. 
 To develop tobacco dependence treatment as rapidly as possible and at as low a cost as 
possible, Parties should use existing resources, workforce and infrastructure, including for 
example community health workers, frontline primary care providers, and tuberculosis 
services.  
 Parties are encouraged to create a sustainable infrastructure which motivates attempts to 
quit, ensures wide access to support, and provides sustainable resources for such support, 
which should be affordable. 
 Tobacco cessation support is a key component of a comprehensive, integrated tobacco 
control programme; offering tobacco users support for their cessation efforts will reinforce 
other tobacco control policies, by increasing support for them and increasing their 
acceptability. 
 Healthcare systems should play a central role in the delivery of cessation support. 
 Parties should follow the evidence base and also keep up with new developments. 
 Tobacco cessation and treatment strategies should be based on the best available evidence; 
there is clear scientific evidence that tobacco dependence treatment is effective, is a cost 
effective healthcare intervention, and thus a worthwhile investment for healthcare systems. 
 Tobacco cessation and treatment strategies should be as inclusive as possible, considering 
the needs of vulnerable groups. 
 
Recommendations 
 
FCTC Article 14 states that “each Party shall develop and disseminate appropriate, comprehensive 
and integrated guidelines based on scientific evidence and best practices, taking into account 
national circumstances and priorities, and shall take effective measures to promote cessation of 
tobacco use and adequate treatment for tobacco dependence”. 
 
The FCTC Article 14 Guidelines set out detailed recommendations for implementation of this 
Article, including on developing infrastructure, the key components of a national treatment system, 
and a stepwise approach to developing cessation support. We urge all stakeholders to use these 
guidelines to inform their thinking about cessation support.    
 
Eventually all Parties should implement all aspects of the FCTC, and the FCTC Article 14 
Guidelines encourage Parties to implement measures beyond those recommended by the guidelines 
(in accordance with the provisions of Article 2.1 of the Convention). However they also clearly 
acknowledge that different countries will be at different stages and will need to implement Article 
14 according to their own priorities and resources. Thus we recommend measures we believe all 
countries can begin implementing now, then measures to be implemented as resources become 
available. 
 
We recommend that countries consider implementing these six core measures immediately: 
 
 Conduct a national situation analysis, as recommended in the FCTC Article 14 Guidelines. 
 Develop and implement an evidence based national cessation strategy and national cessation 
guidelines. 
 Mandate recording tobacco use of all patients in all medical notes. 
 Train healthcare workers to record tobacco use and give brief advice.   
 Help healthcare workers to quit tobacco use. 
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 Integrate brief advice to all tobacco users into the healthcare system. 
 
Some of these measures are relatively low cost (27), and we believe some are essential if healthcare 
systems are to play an active role in helping tobacco users stop. For example, healthcare workers 
raising the issue and giving brief advice will be more likely if tobacco use is recorded in medical 
notes, yet only 20% of countries mandate this (10). The Article 14 Guidelines strongly emphasise 
using existing infrastructure as far as possible, both to keep costs down and to ensure as broad 
coverage as possible. They mention infrastructure like the primary healthcare system, and services 
to treat tuberculosis and HIV/AIDS, and in some countries dental services and NCD programmes 
could also be involved. The first WHO Report on the Global Tobacco Epidemic (the MPOWER 
package) recommends that tobacco cessation advice be incorporated into primary healthcare 
services (36). We believe that whatever stage countries are at in implementing other articles of the 
FCTC, they could be implementing these six core measures. 
 
We recommend that as resources become available countries implement these additional measures: 
 
 Offer mobile phone text messaging support and other evidence based web support (very low 
cost and accessible). 
 Make evidence based affordable cessation medicines and less harmful forms of nicotine 
more available. 
 Offer evidence based telephone quitlines and put the number on pack warnings. 
 Expand training to include other healthcare workers, for example, village health workers. 
 Offer specialist face-to-face cessation support. 
 Establish mass communication and education programmes that encourage cessation and 
promote cessation support. 
 
Keeping up-to-date with the scientific evidence 
 
The FCTC Article 14 Guidelines urge Parties to follow the evidence base, keep under review the 
emerging scientific evidence, and be open to innovative approaches to promote tobacco cessation 
(2). Since the Article 14 Guidelines were adopted in 2010 for example, new research has emerged 
on text messaging and on less harmful forms of nicotine delivery. Thus national cessation 
guidelines need to be reviewed and updated periodically to include new interventions. An 
increasing body of evidence demonstrates the effectiveness of text messaging, a measure with 
enormous potential because of its potential population reach and low cost. Research is also 
developing on different forms of nicotine delivery. Clearly any cessation guideline published in 
1980 would be seriously out-of-date by1990 because of the advent of nicotine replacement therapy 
(NRT) – itself an alternative form of nicotine delivery when it was first licensed – now affordable in 
many countries, and on the WHO Essential Medicines List (37). Two recent authoritative 
publications recognise the continuum of risk from using nicotine products (38, 39). Based on this 
idea, differential taxes have been proposed that discourage use of the most dangerous forms of 
nicotine yielding products (40). We therefore urge countries to remember that it is the nicotine in 
tobacco products that keeps people using them, but it is primarily the toxins in the tobacco and 
tobacco smoke that cause the illness and death, and to keep under review all potential options for 
tobacco cessation, including, for some, the continued use of nicotine. 
 
Focusing on affordability 
 
Many tools exist to help countries implement or improve their provision of tobacco cessation 
support, including the recommendations of the FCTC Article 14 Guidelines themselves (for 
example to include the quitline number on tobacco packaging) (2), WHO resources (41, 42, 43), 
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and tools to help countries conduct a national situation analysis – recommended in the Article 14 
Guidelines – and access other related resources (44). West and colleagues have published a review 
of effectiveness and affordability, which includes an excel calculator that permits a country to input 
its own national data in order to calculate the affordability of a cessation intervention (27). 
Potentially low cost evidence based medications are available (45), and countries should also 
examine how to make medications more affordable, through bulk buying for example, and by 
including some on their national essential medicines lists. Many countries base their national lists 
on WHO’s essential medicines list (37), which includes nicotine chewing gum and nicotine patch. 
We also urge countries to consider increasing funding for tobacco control and cessation support 
through earmarked tax increases (34), a measure recommended in the FCTC Article 6 Guidelines.  
 
Obviously a key challenge in providing specialist face-to-face cessation support is cost, but another 
issue is reach. Even in some countries that do provide specialist support it is only accessible to a 
small fraction of the population. This is why the Article 14 Guidelines encourage Parties to consider 
using existing, rather than creating new, infrastructures. However many countries do have the 
resources to offer specialist support, and the Article 14 guidelines include a number of 
recommendations for these, including that it could be delivered by a variety of healthcare or other 
trained workers, in a wide variety of settings, should be easily accessible to tobacco users, and 
where possible should be provided free or at an affordable cost. The guidelines also emphasize the 
importance of mass communication programmes that promote cessation. 
 
Conclusions 
 
Implementation of FCTC Article 14 has been slow. Accelerating its implementation to complement 
implementation of other Articles, including those promoting tax increases, smokefree public places 
and graphic health warnings, will save lives, prevent numerous debilitating illnesses, and bring 
economic benefits. The availability of effective, broad-reach, low-cost interventions, and methods to 
help countries select affordable treatments (27) will remove significant barriers to the development of 
tobacco cessation support and make Article 14 implementation both eminently feasible and a 
significant contributor to global health. 
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Terminology 
 
The terms tobacco dependence treatment and tobacco cessation support are used interchangeably 
here and in the FCTC Article 14 Guidelines, which also note that treatment includes broad reach 
Improving implementation of FCTC Article 14 
 
7 
 
low intensity population approaches, behavioural support, and effective medications. This article is 
about stopping smoking and other forms of tobacco use. 
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